Northern Trust’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

Northern Trust’s Portfolio ORTX Stock Details ORTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-2,605	Closed	-$114K	–	4767
2021 Q2	$114K	Sell	2,605 -1,808	-41%	-$101K	﹤0.01%	4333
2021 Q1	$320K	Buy	4,413 +891	+25%	+$63.3K	﹤0.01%	3958
2020 Q4	$152K	Sell	3,522 -104	-3%	-$4.66K	﹤0.01%	4030
2020 Q3	$149K	Buy	3,626 +5	+0.1%	+$258	﹤0.01%	3869
2020 Q2	$217K	Sell	3,621 -151	-4%	-$13.8K	﹤0.01%	3739
2020 Q1	$284K	Sell	3,772 -182	-5%	-$21K	﹤0.01%	3589
2019 Q4	$544K	Sell	3,954 -23	-0.6%	-$2.8K	﹤0.01%	3537
2019 Q3	$472K	Buy	3,977 +3	+0.1%	+$419	﹤0.01%	3552
2019 Q2	$556K	Buy	3,974 +370	+10%	+$65K	﹤0.01%	3529
2019 Q1	$644K	Sell	3,604 -77	-2%	-$11.6K	﹤0.01%	3476
2018 Q4	$579K	Buy	+3,681	New	+$549K	﹤0.01%	3520

Other funds holding ORTX

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Northern Trust's ORTX Position: Q3 2021 in Review

Northern Trust sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q3 2021, closing a stake of 2,605 shares — an estimated $114K sold.

Northern Trust first reported a position in ORTX in Q4 2018 and held it in 11 quarters. The position peaked at $644K in Q1 2019. 79 funds tracked by Wall St. Rank hold ORTX as of Q3 2021.

Northern Trust reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q3 2021 after selling out during the quarter.
Northern Trust sold 2,605 Orchard Therapeutics plc American Depositary Shares shares in Q3 2021, an estimated $114K.
Northern Trust first reported a position in Orchard Therapeutics plc American Depositary Shares in Q4 2018 and held it in 11 quarters.
Northern Trust's Orchard Therapeutics plc American Depositary Shares position peaked at $644K in Q1 2019.
79 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q3 2021.

Based on Northern Trust's 13F filing for Q3 2021, filed 15 Nov 2021.